David Marek
2021 - Myovant Sciences Ltd.
In 2021, David Marek earned a total compensation of $6.2M as Principal Executive Officer at Myovant Sciences Ltd., a 39% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $473,000 |
|---|---|
| Option Awards | $2,407,333 |
| Salary | $750,000 |
| Stock Awards | $2,410,027 |
| Other | $207,149 |
| Total | $6,247,509 |
Marek received $2.4M in stock awards, accounting for 39% of the total pay in 2021.
Marek also received $473K in non-equity incentive plan, $2.4M in option awards, $750K in salary and $207.1K in other compensation.
Rankings
In 2021, David Marek's compensation ranked 2,024th out of 12,405 executives tracked by ExecPay. In other words, Marek earned more than 83.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,024 out of 12,405 | 84th |
Division Manufacturing | 771 out of 5,494 | 86th |
Major group Chemicals And Allied Products | 301 out of 2,369 | 87th |
Industry group Drugs | 260 out of 2,090 | 88th |
Industry Pharmaceutical Preparations | 168 out of 1,537 | 89th |
Source: SEC filing on July 27, 2022.
Marek's colleagues
We found three more compensation records of executives who worked with David Marek at Myovant Sciences Ltd. in 2021.